Trumenba MenB
Selected indexed studies
- MenB-FHbp Meningococcal Group B Vaccine (Trumenba(®)): A Review in Active Immunization in Individuals Aged ≥ 10 Years. (Drugs, 2018) [PMID:29380290]
- Meningococcal Vaccinations. (Infect Dis Ther, 2016) [PMID:27086142]
- Characteristics of a new meningococcal serogroup B vaccine, bivalent rLP2086 (MenB-FHbp; Trumenba®). (Postgrad Med, 2016) [PMID:27467048]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Meningococcal Vaccinations. (2016) pubmed
- First use of Trumenba (MenB-fHbp) vaccine to control a nursery outbreak of serogroup B invasive meningococcal disease involving children previously immunised with Bexsero (4CMenB), England, November 2023. (2026) pubmed
- MenB-FHbp Meningococcal Group B Vaccine (Trumenba(®)): A Review in Active Immunization in Individuals Aged ≥ 10 Years. (2018) pubmed
- Characteristics of a new meningococcal serogroup B vaccine, bivalent rLP2086 (MenB-FHbp; Trumenba®). (2016) pubmed
- A Phase 1, randomized, double-blind, placebo-controlled, single- and multiple-dose escalation study to evaluate the safety and pharmacokinetics/pharmacodynamics of PF-06835375, a C-X-C chemokine receptor type 5 directed antibody, in patients with systemic lupus erythematosus or rheumatoid arthritis. (2024) pubmed
- Two-Dose MenB-FHbp (Trumenba) for Meningococcal Disease Prevention. (2017) pubmed
- Introduction of a second MenB vaccine into Europe - needs and opportunities for public health. (2019) pubmed
- A physician's guide to the 2-dose schedule of MenB-FHbp vaccine. (2019) pubmed
- Updated Recommendations for Use of MenB-FHbp Serogroup B Meningococcal Vaccine - Advisory Committee on Immunization Practices, 2016. (2017) pubmed
- Serum bactericidal activity against circulating and reference strains of meningococcal serogroup B in the United States: A review of the strain coverage of meningococcal serogroup B (MenB) vaccines in adolescents and young adults. (2023) pubmed